Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
See All Experts
story of the week
Published in Primary Care and
1 other channel

Journal Scan / Consensus and Guidelines · September 28, 2021

PSA Testing as Early Detection Strategy for Prostate Cancer

European Urology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Joshua Cohn MD, FPMRS

European Urology
Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021
Eur Urol 2021 Aug 15;[EPub Ahead of Print], H Van Poppel, MJ Roobol, CR Chapple, JWF Catto, J N'Dow, J Sønksen, A Stenzl, M Wirth

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated